Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company engaged in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers medical aesthetics solutions, including filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, and skin care, as well as drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, along with modern Chinese medicine and industrial hemp products. It also provides general hospital services. Founded in 2001, the company is based in Wan Chai, Hong Kong.